Labshake search
Citations for Stemcell Technologies :
101 - 150 of 1085 citations for 2 Amino 6 chloro 9 3 5 di O p toluoyl beta D 2 deoxyribofurnanosyl purine since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cancer Biology 2024Quote: ... heparin (2 µg/ml; Stemcell Technologies, Inc.); 20 ng/mL human EGF and FGFb and 10 ng/mL platelet derived growth factors AA and BB (PeproTech ...
-
bioRxiv - Bioengineering 2021Quote: ... at 5×105 LSK/mL and cultured for 2 h at 5% CO2 and 37 °C in 500 µL SFEM media (#09650, Stemcell Technologies) supplemented with 100 ng/mL SCF (#250-03 ...
-
bioRxiv - Cell Biology 2022Quote: ... then gently detached with Accutase and reseeded as 2-5×104 cells/cm2 in mTeSR medium containing 10uM Y-27632 (#72304, STEMCELL Technologies) ROCK inhibitor (removed after 48h and exchanged for fresh medium without ROCK inhibitor) ...
-
bioRxiv - Physiology 2022Quote: ... Proteases were neutralized with medium containing 10% FBS and resulting suspension of cells were incubated in a flask at 37°C 5% CO2 for 2 hours in PneumaCult-Ex Plus medium (Cat. 05040, Stemcell Technologies) with 100 U/mL penicillin and 100 μg/mL streptomycin to remove non-epithelial cells ...
-
bioRxiv - Cancer Biology 2021Quote: ... Mouse anti-Beta Tubulin (STEMCELL Technologies; 1:500); Rabbit anti-Olig2 (PhosphoSolutions ...
-
bioRxiv - Immunology 2021Quote: Female C57BL/6 mice received a single dose of mouse recombinant CSF-3 (StemCell Technologies) at 0.25mg/kg in sterile PBS ...
-
bioRxiv - Developmental Biology 2023Quote: ... differentiating cells were confluent again and split 1:3-1:4 into Step 2 differentiation medium: BrainPhys Neuronal Medium (STEMCELL Technologies, cat# 05790), 1X N2 ...
-
bioRxiv - Neuroscience 2021Quote: ... IPSCs (Wicell UCSD021i-3-9) were differentiated into Hematopoietic progenitor cells (HPCs) using the STEMdiff™ Hematopoietic Kit (Stem Cell Technologies # 05310) according to manufacturer instructions ...
-
bioRxiv - Developmental Biology 2023Quote: ... Cells were passaged every 3–5 days with ReLeSR (STEMCELL Technologies). All cells used had a normal diploid karyotype.
-
bioRxiv - Cancer Biology 2023Quote: ... and 2 H3.1-K27M (GSC3, GSC4) cellular models were grown in NeurocultTM medium supplemented with heparin (2 μg/mL, Stemcell Technologies), EGF/FGF (20ng/mL ...
-
bioRxiv - Bioengineering 2021Quote: hiPSC-derived endothelial cells (hECs) were differentiated as previously described.[85] hiPSCs were subjected to 5 μM CHIR99021 in STEMdiff APEL 2 Medium (STEMCELL Technologies, 05270) for 24 hours ...
-
bioRxiv - Cell Biology 2024Quote: ... cells were treated with cardiomyocytes differentiation basic medium (2 mM L-glutamine RPMI-1640 plus 1x B27 minus insulin) containing 5 μM CHIR99021 (STEMCELL Technologies, Canada) for 48 hours ...
-
bioRxiv - Biophysics 2024Quote: ... Labeled ASCs were suspended in 2 mL PBS and incubated for 5 minutes in an EasySep™ magnet (Stemcell Technologies, Vancouver, CAN) to separate the iron-labeled cells from the unlabeled.
-
bioRxiv - Cancer Biology 2020Quote: ... heparin (2 μg/ml; Stem Cell Tech, #07980), and Antibiotic-Antimycotic solution (0.1% ...
-
bioRxiv - Genetics 2022Quote: ... 2 μM doxycycline and CloneR supplement (StemCell Technologies) to enhance the viability of single cells ...
-
bioRxiv - Neuroscience 2020Quote: ... and heparin (2 μg/mL, StemCell Technologies, #07980).
-
bioRxiv - Cancer Biology 2020Quote: ... 2 μg/mL Heparin (Stem Cell Technologies #07980) and L-glutamine (2mM ...
-
bioRxiv - Neuroscience 2021Quote: ... supplemented with 2% NeuroCult SM1 supplement (STEMCELL Technologies) and 1% penicillin/streptomycin (Gibco) ...
-
bioRxiv - Cell Biology 2021Quote: ... containing 2% NeuroCult SM1 supplement (StemCell Technologies, 05711), 1% L-glutamine (Corning ...
-
bioRxiv - Cancer Biology 2021Quote: ... and 2 μg/mL heparin (StemCell Technologies, #07980). All cultures were used within the first 20 passages of generation ...
-
bioRxiv - Immunology 2020Quote: ... with 2 mL Spleen Dissociation Medium (STEMCELL Technologies) and homogenized using the Miltenyi GentleMacs dissociator ...
-
bioRxiv - Cancer Biology 2020Quote: ... and 2 μg/mL heparin (StemCell Technologies, #07980); 500 μL of 25% BSA (Millipore-Sigma ...
-
bioRxiv - Cancer Biology 2020Quote: ... and 2 μg/mL heparin (Stem Cell Technologies), as previously described (Tominaga et al. ...
-
bioRxiv - Neuroscience 2022Quote: ... and 2 µM of XAV939 (STEMCELL Technologies, #72674) were added to induce cerebro-cortical differentiation ...
-
bioRxiv - Neuroscience 2022Quote: ... 2 mL of ReLeSR (StemCell Technologies, cat.no. 05872) solution was applied for 30 seconds at room temperature ...
-
bioRxiv - Neuroscience 2022Quote: ... and 2 μM of XAV939 (#72674, StemCell Technologies). The medium was changed daily until day 11 ...
-
bioRxiv - Immunology 2022Quote: ... and/or rat serum (2%; Stem Cell Technologies) for 5min on ice prior to adding fluorescent antibodies (BioLegend ...
-
bioRxiv - Neuroscience 2023Quote: ... 2% NeuroCult™ SM1 (STEMCELL Technologies, Cat# 05711), 1% N-2 Supplement (Thermo Scientific ...
-
bioRxiv - Cancer Biology 2023Quote: ... 2×105 hDR4+ HSCs (purchased from Stemcell Technologies Inc ...
-
bioRxiv - Bioengineering 2023Quote: ... and 10 μMY27632 (Stemcell Technologies, 129830-38-2)) on day 0 ...
-
bioRxiv - Cancer Biology 2024Quote: ... 100 ng/mL IGF-2 (STEMCELL Technologies #78023), and 10 μM Y-27632 (STEMCELL Technologies #72308 ...
-
bioRxiv - Neuroscience 2023Quote: ... iPSCs were passaged every 5-6 days using ReLeSR dissociation reagent (STEMCELL Technologies, 05872) and used for hematopoietic stem cell differentiation with STEMdiff Hematopoietic kit (STEMCELL Technologies ...
-
bioRxiv - Molecular Biology 2022Quote: ... at 37°C and passaged every 5-6 days using ReLeSR (Stem Cell Technologies).
-
bioRxiv - Pharmacology and Toxicology 2024Quote: ... Cell passaging was done every 5-6 days with ReLeSR™ (Stem Cell Technologies) according to the manufacturer’s instructions ...
-
bioRxiv - Immunology 2024Quote: ... and DNaseI (9003-98-9, STEMCELL Technologies) for 40 min at 37°C in complete HBSS (21-023-CV ...
-
bioRxiv - Cell Biology 2021Quote: ... for 5 min followed by a 3 min treatment with 5 mg/mL dispase (Stem Cell Technologies, 07913) and 1 mg/mL DNase I (Sigma ...
-
bioRxiv - Neuroscience 2021Quote: ... placed in a stereotaxic frame and injected with either 100,000 hNSCs per side (2 μl/injection) or vehicle (2 μl HBSS with 20 ng/ml epidermal growth factor [STEMCELL Technologies, #78003] and human fibroblast growth factor [STEMCELL ...
-
bioRxiv - Neuroscience 2024Quote: ... Cells were centrifuged at 200 x g for 2 min and resuspended in neural media (NM; Supplementary Table 2) supplemented with 0.02 µg/mL FGF2 (StemCell Technologies, #78003) and 0.02 µg/mL EGF (StemCell Technologies ...
-
IRF1 regulates self-renewal and stress-responsiveness to support hematopoietic stem cell maintenancebioRxiv - Cell Biology 2023Quote: ... Briefly, PB was collected in FACS buffer (PBS, 2 % FBS, 2 mM EDTA) supplemented with 0.0004 % heparin solution (STEMCELL Technologies Inc.). RBCs was removed by incubation at 37 °C for 25 minutes with 1 % Dextran solution in PBS ...
-
bioRxiv - Genetics 2024Quote: ... Contractile VSMCs were then induced with N2B27 supplemented with 2 ng/ml Activin A and 2 µg/ml Heparin (STEMCELL Technologies) for 5 days ...
-
bioRxiv - Genomics 2024Quote: ... Contractile VSMCs were subsequently induced by culturing in N2B27 medium containing 2 ng/ml Activin A and 2 µg/ml Heparin (STEMCELL Technologies) for 6 days ...
-
bioRxiv - Bioengineering 2021Quote: ... T cells were frozen at 1-2 × 107 cells/mL and NK cells were frozen at 5 × 106 cells/mL in CryoStor CS10 (STEMCELL Technologies, Cambridge, MA) and thawed into culture as needed ...
-
bioRxiv - Neuroscience 2024Quote: ... Embryoid body media (EBM) was used for days 2 to 11 (Supplementary Table 2) and supplemented with 10 µM SB431542 (Stemcell Technologies, #72234), 0.1 µM LDN193189 (MedChemExpress ...
-
bioRxiv - Immunology 2024Quote: ... splenocytes were washed in PBS and resuspended in PBS containing 2%FBS and 2 mM EDTA before negative selection using EasySep Mouse Pan-B Cell Isolation Kit (StemCell Technologies, #19844A) following manufacturer instructions ...
-
bioRxiv - Molecular Biology 2021Quote: ... and human recombinant IL-2 (Stemcell Technologies, Vancouver, Canada). Activated CD4+ T cells were transfected with pVax-CasRx and gRNA plasmids by nucleofection using Lonza 4d nucleofector ...
-
bioRxiv - Bioengineering 2022Quote: ... supplemented with 2 mg/mL heparin (#07980; STEMCELL Technologies) on 10 μg/mL human plasma fibronectin (#FC010 ...
-
bioRxiv - Cancer Biology 2022Quote: ... Fibroblast Growth Factor-2 (FGF2, StemCell Technologies Cat#78134.1), Vascular Endothelial Growth Factor-A (VEGF-165 ...
-
bioRxiv - Cancer Biology 2020Quote: ... supplemented with 2 µg/ml heparin sulfate (STEMCELL Technologies) or SFM supplemented with 20 ng/ml human recombinant epidermal growth factor (hEGF ...
-
bioRxiv - Cancer Biology 2021Quote: ... and heparin sulfate (2 µg/mL; 07980, STEMCELL Technologies). The plates were kept in a 37°C ...
-
bioRxiv - Developmental Biology 2021Quote: ... 2 mg/ml DNase I (Stem Cell Technologies, 07900)) ...